The DOI matches its Crossref record; 365 of the 365 references it cites were found in a registry or an index.
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2012 on the long-term treatment of bipolar disorder
Open accessAbstract
OBJECTIVES: These guidelines are based on a first edition that was published in 2004, and have been edited and updated with the available scientific evidence up to October 2012. Their purpose is to supply a systematic overview of all scientific evidence pertaining to the long-term treatment of bipolar disorder in adults. METHODS: Material used for these guidelines are based on a systematic literature search using various data bases. Their scientific rigor was categorised into six levels of evidence (A-F) and different grades of recommendation to ensure practicability were assigned. RESULTS: Maintenance trial designs are complex and changed fundamentally over time; thus, it is not possible to give an overall recommendation for long-term treatment. Different scenarios have to be examined separately: Prevention of mania, depression, or an episode of any polarity, both in acute responders and in patients treated de novo. Treatment might differ in Bipolar II patients or Rapid cyclers, as well as in special subpopulations. We identified several medications preventive against new manic episodes, whereas the current state of research into the prevention of new depressive episodes is less satisfactory. Lithium continues to be the substance with the broadest base of evidence across treatment scenarios. CONCLUSIONS: Although major advances have been made since the first edition of this guideline in 2004, there are still areas of uncertainty, especially the prevention of depressive episodes and optimal long-term treatment of Bipolar II patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
A Rating Scale for Mania: Reliability, Validity and Sensitivity
Young, R. C., Biggs, J. T., Ziegler, V. E., & Meyer, D. A. (1978) · British Journal of Psychiatry · doi:10.1192/bjp.133.5.429 · Cited by 8,744
Yatham, L., & Malhi, G. (2011) · Oxford University Press eBooks · doi:10.1093/med/9780199562305.001.0001 · Cited by 3,506
The world health report 2001 - Mental health: new understanding, new hope
Sayers, J. G. (2001) · Europe PMC (PubMed Central) · doi:10.1590/s0042-96862001001100014 · Cited by 3,123
(1984) · The Lancet · doi:10.1016/s0140-6736(84)92810-1 · Cited by 2,925
Pharmaceutical industry sponsorship and research outcome and quality: systematic review
Lexchin, J., Bero, L. A., Djulbegovic, B., & Clark, O. (2003) · BMJ · doi:10.1136/bmj.326.7400.1167 · Cited by 2,147 · cited 1×
“Another methodological limitation is sponsor bias (Lexchin et al 2003;Perlis et al 2005;Lexchin and Light 2006;Heres et al 2006) inherent in most single studies on which the guidelines are based.”
BackgroundFrank, E. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810330075011 · Cited by 1,959 · cited 1×
“In the original proposal by Frank et al., developed for major depression (Frank et al 1991b), recovery was achieved when there was remission even in the absence of any treatment.”
Manic-Depressive Insanity and Paranoia.
(1921) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1921.02630330070026 · Cited by 1,573
Goodwin, G., Haddad, P., Ferrier, I., Aronson, J., Barnes, T., Cipriani, A., Coghill, D., Fazel, S., Geddes, Jr., Grunze, H., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116636545 · Cited by 1,309
Self-citation
Research works printed but not linked: 52
- Abou-Auda HS, 2008, Bipolar Disord, 10, 369, 10.1111/j.1399-5618.2007.00549.x · doi:10.1111/j.1399-5618.2007.00549.x
- Agarkar S, 2011, J Neuropsychiatry Clin Neurosci, 23, 12, 10.1176/jnp.23.2.jnpe12 · doi:10.1176/jnp.23.2.jnpe12
- Anderson J, 2000, J Rheumatol, 27, 540
- Angst J, 1981, Handbook of Biological Psychiatry, 225
- Angst J, 1995, Schweiz Arch Neurol Psychiatr, 146, 17
- Becker D, 2002, Eur Psychiatry, 17, 349, 10.1016/S0924-9338(02)00688-0 · doi:10.1016/s0924-9338(02)00688-0
- Benabarre A, 2009, Actas Esp Psiquiatr, 37, 143
- Bowden CL, 1997, Psychopharmacol Bull, 33, 693
- Bowden CL, 2012, Acta Psychiatry, 64, 1013
- Calabrese J, 2003, J Clin
- Carta MG, 2006, Clin Pract Epidemiol Ment Health, 2, 19, 10.1186/1745-0179-2-19 · doi:10.1186/1745-0179-2-19
- Dunner DL, 1998, J Clin Psychiatry, 59, 48
- Emrich HM, 1992, Prog Neuropsychopharmacol Biol Psychiatry, 16, 691, 10.1016/0278-5846(92)90025-A · doi:10.1016/0278-5846(92)90025-a
- Ernst CL, 2002, J Clin Psychiatry, 63, 42
- Fitzgerald BJ, 2002, Pharmacotherapy, 22, 1500, 10.1592/phco.22.16.1500.33697 · doi:10.1592/phco.22.16.1500.33697
- Garcia-Lopez A, 2001, Actas Esp Psiquiatr, 29, 327
- Ghaemi SN, 2004, Ann Clin Psychiatry, 16, 69, 10.1080/10401230490453103 · doi:10.1080/10401230490453103
- 10.4088/JCP.08m04301 · DOI
- Goncalves N, 1985, Nervenarzt, 56, 43
- Goodwin FK, 2002, J Clin Psychiatry, 63, 5
- Grande I, 2012, Int J Neuropsychopharmacol, 1
- Greil W, 1999, Int Clin Psychopharmacol, 14, 283, 10.1097/00004850-199914050-00003 · DOI
- Greil W, 1999, Int Clin Psychopharmacol, 14, 277, 10.1097/00004850-199914050-00002 · DOI
- Grunze H, 2004, Valproat bei manisch-depressiven (bipolaren) Erkrankungen
- Harvey PD, 2006, J Clin Psychiatry, 67, 14
- Hayes SG, 1989, J Clin Psychiatry, 50, 35
- Hullin RP, 1972, Lancet i, 1044
- Kessing LV, 2011, J Psychopharmacol
- Lancon C, 1996, Encephale, 22, 468
- Lebowitz BK, 2001, Neuropsychiatry Neuropsychol Behav Neurol, 14, 177
- Moskowitz AS, 1991, J Clin Psychopharmacol, 11, 272, 10.1097/00004714-199108000-00020 · doi:10.1097/00004714-199108000-00020
- Murru A, 2011, Eur Psychiatry
- Nolen WA, 2008, Richtlijn bipolaire stoornissen
- Placidi GF, 1986, J Clin Psychiatry, 47, 490
- Popovic D, 2011, Eur Neuropsychopharmacol
- Puri BK, 1995, Br J Clin Pract, 49, 333, 10.1111/j.1742-1241.1995.tb10004.x · doi:10.1111/j.1742-1241.1995.tb10004.x
- Puzynski S, 1984, Psychopharmacol Bull, 20, 151
- Quitkin FM, 1981, Psychopharmacol Bull, 17, 142
- Riedel M, 2010, Expert Opin Drug Saf, 9, 659, 10.1517/14740338.2010.486787 · doi:10.1517/14740338.2010.486787
- Sachdev PS, 1986, Am J Psychiatry, 143, 942, 10.1176/ajp.143.7.942 · doi:10.1176/ajp.143.7.942
- Sachs GS, 2000, Postgrad Med Spec Report, 1
- Sartorius N, 2007, Int J Neuropsychopharmacol, 10, 1
- Singh V, 2012, Bipolar Disord, 14, 13
- Szabo CP, 1993, S Afr Med J, 83, 442
- Vieta E, 2011, New Engl J Med, 364, 1581
- 10.1016/j.jad.2009.02.028 · DOI
- Viguera AC, 2007, J Clin Psychiatry, 68, 29
- World Health Organization, 1992, Clinical descriptions and diagnostic guidelines
- Yoshimura R, 2006, Pharmacopsychiatry, 39, 233, 10.1055/s-2006-951386 · doi:10.1055/s-2006-951386
- Young AH, 2012, World J Biol Psychiatry
- Zarate CA, 1995, J Clin Psychiatry, 56, 108
- Zis AP, 1980, Psychopharmacol Bull, 16, 47
Cited by
Grande, I., Berk, M., Birmaher, B., & Vieta, E. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00241-x · Cited by 1,710
Self-citationMalhi, G. S., Bassett, D., Boyce, P., Bryant, R., Fitzgerald, P. B., Fritz, K., Hopwood, M., Lyndon, B., Mulder, R., Murray, G., et al. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415617657 · Cited by 842
Mobile Apps for Bipolar Disorder: A Systematic Review of Features and Content Quality
Nicholas, J., Larsen, M. E., Proudfoot, J., & Christensen, H. (2015) · Journal of Medical Internet Research · doi:10.2196/jmir.4581 · Cited by 438
Solmi, M., Murru, A., Pacchiarotti, I., Undurraga, J., Veronese, N., Fornaro, M., Stubbs, B., Monaco, F., Vieta, E., Seeman, M., et al. (2017) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s117321 · Cited by 438
Self-citationLithium and suicide in mood disorders: Updated meta‐review of the scientific literature
Smith, K. A., & Cipriani, A. (2017) · Bipolar Disorders · doi:10.1111/bdi.12543 · Cited by 247
Metadata
- Authors
- Grunze, H., Vieta, E., Goodwin, G. M., Bowden, C., Licht, R. W., Möller, H.-J., Kasper, S., & on behalf of the WFSBP Task Force on Treatment Guidelines for Bipolar Disorders
- Venue
- The World Journal of Biological Psychiatry
- Publisher
- Informa UK Limited
- Published
- 2013-03-13
- Volume
- 14
- Issue
- 3
- Pages
- 154-219
- ISSN
- 1562-2975 (ISSN-L)
- 1814-1412
- OpenAlex
- W2170882187
- Cited by
- 421
- References
- 365
- FWCI
- 31.05
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2012 on the long-term treatment of bipolar disorder. https://app.cochat.ai/papers/10.3109/15622975.2013.770551
- The paper
- Grunze, H., Vieta, E., Goodwin, G. M., Bowden, C., Licht, R. W., Möller, H.-J., Kasper, S., & on behalf of the WFSBP Task Force on Treatment Guidelines for Bipolar Disorders. (2013). The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2012 on the long-term treatment of bipolar disorder. The World Journal of Biological Psychiatry. https://doi.org/10.3109/15622975.2013.770551
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.